Abstract
Purpose
The purpose of the study is to assess cognitive function in papillary thyroid cancer, one type of differentiated thyroid cancer, and to identify factors associated with cognitive dysfunction.
Methods
Korean women treated with papillary thyroid cancer post thyroidectomy (n = 90) and healthy women similar in age and educational level (n = 90) performed attention and working memory tests and completed self-report questionnaires on cognitive complaints, psychological distress, symptom distress, and cultural characteristics. Comparative and multivariable regression analyses were performed to determine differences in cognitive function and possible predictors of neurocognitive performance and cognitive complaints.
Results
Thyroid cancer survivors performed and perceived their function to be significantly worse on tests of attention and working memory compared to individuals without thyroid cancer. Regression analyses found that having thyroid cancer, older age, and lower educational level were associated with worse neurocognitive performance, while greater fatigue, more sleep problems, and higher levels of childrearing burden but not having thyroid cancer were associated with lower perceived effectiveness in cognitive functioning.
Conclusions
Findings suggest that women receiving thyroid hormone replacement therapy after thyroidectomy for papillary thyroid cancer are at risk for attention and working memory problems. Coexisting symptoms and culture-related women’s burden affected perceived cognitive dysfunction. Health care providers should assess for cognitive problems in women with thyroid cancer and intervene to reduce distress and improve quality of life.
Similar content being viewed by others
References
La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E (2015) Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136:2187–2195. doi:10.1002/ijc.29251
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921. doi:10.1158/0008-5472.CAN-14-0155
Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, Lee KH (2015) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 47:127–141. doi:10.4143/crt.2015.060
Aschebrook-Kilfoy B, James B, Nagar S, Kaplan S, Seng V, Ahsan H, Angelos P, Kaplan EL, Guerrero MA, Kuo JH, Lee JA, Mitmaker EJ, Moalem J, Ruan DT, Shen WT, Grogan RH (2015) Risk factors for decreased quality of life in thyroid cancer survivors: initial findings from the North American thyroid cancer survivorship study. Thyroid 25:1313–1321. doi:10.1089/thy.2015.0098
Von Ah D, Russell KM, Storniolo AM, Carpenter JS (2009) Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncol Nurs Forum 36:326–336. doi:10.1188/09.ONF.326-334
Askren MK, Jung M, Berman MG, Zhang M, Therrien B, Peltier S, Ossher L, Hayes DF, Reuter-Lorenz PA, Cimprich B (2014) Neuromarkers of fatigue and cognitive complaints following chemotherapy for breast cancer: a prospective fMRI investigation. Breast Cancer Res Treat 147:445–455. doi:10.1007/s10549-014-3092-6
Berman MG, Askren MK, Jung M, Therrien B, Peltier S, Noll DC, Zhang M, Ossher L, Hayes DF, Reuter-Lorenz PA, Cimprich B (2014) Pretreatment worry and neurocognitive responses in women with breast cancer. Health Psychol 33:222–231. doi:10.1037/a0033425
Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, Dimsdale JE, Rissling M, He F, Ancoli-Israel S (2009) Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology 18:187–194. doi:10.1002/pon.1412
Merriman JD, Von Ah D, Miaskowski C, Aouizerat BE (2013) Proposed mechanisms for cancer- and treatment-related cognitive changes. Semin Oncol Nurs 29:260–269. doi:10.1016/j.soncn.2013.08.006
Ritchie M, Yeap BB (2015) Thyroid hormone: influences on mood and cognition in adults. Maturitas 81:266–275. doi:10.1016/j.maturitas.2015.03.016
Cimprich B, So H, Ronis DL, Trask C (2005) Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer. Psychooncology 14:70–78. doi:10.1002/pon.821
Jung MS, Cimprich B (2014) Cognitive deficits in Korean women treated with chemotherapy for breast cancer. Cancer Nurs 37:E31–E42. doi:10.1097/NCC.0b013e3182980383
Burmeister LA, Ganguli M, Dodge HH, Toczek T, DeKosky ST, Nebes RD (2001) Hypothyroidism and cognition: preliminary evidence for a specific defect in memory. Thyroid 11:1177–1185. doi:10.1089/10507250152741037
Botella-Carretero JI, Galan JM, Caballero C, Sancho J, Escobar-Morreale HF (2003) Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 10:601–610
Jaracz J, Kucharska A, Rajewska-Rager A, Lacka K (2012) Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma. J Endocrinol Investig 35:760–765. doi:10.3275/8013
Moon JH, Ahn S, Seo J, Han JW, Kim KM, Choi SH, Lim S, Park YJ, do Park J, Kim KW, Jang HC (2014) The effect of long-term thyroid-stimulating hormone suppressive therapy on the cognitive function of elderly patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 99:3782–3789. doi:10.1210/jc.2013-4454
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, Falloon K, Hatcher S (2010) Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 8:348–353. doi:10.1370/afm.1139
Vardy J, Tannock I (2007) Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 63:183–202. doi:10.1016/j.critrevonc.2007.06.001
Bender CM, Thelen BD (2013) Cancer and cogntive changes: the complexity of the problem. Semin Oncol Nurs 29:232–237
Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, 4th edn. Oxford University Press, Oxford
Visovatti MA, Reuter-Lorenz PA, Chang AE, Northouse L, Cimprich B (2016) Assessment of cognitive impairment and complaints in individuals with colorectal cancer. Oncol Nurs Forum 43:169–178. doi:10.1188/16.ONF.43-02AP
Kang Y, Chin J, Na DL, Lee J, Park JS (2000) A normative study of the Korean version of controlled oral word association test (COWAT) in the elderly. Korean J Clin Psychol 19:385–392
Cimprich B, Visovatti M, Ronis DL (2011) The Attentional Function Index—a self-report cognitive measure. Psychooncology 20:194–202. doi:10.1002/pon.1729
Jung MS (2012) Cognitive function in Korean women diagnosed with early stage breast cancer. Doctoral dissertateion. University of Michigan, Ann Arbor
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13:63–74
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Sohn SI, do Kim H, Lee MY, Cho YW (2012) The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index. Sleep Breath 16:803–812. doi:10.1007/s11325-011-0579-9
Kelly W (2004) A brief measure of general worry: the three item worry index. N Am J Psychol 6:219–226
Chon K, Kim K (2008) Life stress and coping styles of Korean housewives. Korean J Health Psychol 8:1–39
Pearlin LI, Schooler C (1978) The structure of coping. J Health Soc Behav 19:2–21
Lindner OC, Phillips B, McCabe MG, Mayes A, Wearden A, Varese F, Talmi D (2014) A meta-analysis of cognitive impairment following adult cancer chemotherapy. Neuropsychology 28:726–740. doi:10.1037/neu0000064
Hermelink K, Kuchenhoff H, Untch M, Bauerfeind I, Lux MP, Buhner M, Manitz J, Fensterer V, Munzel K (2010) Two different sides of ‘chemobrain’: determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psychooncology 19:1321–1328. doi:10.1002/pon.1695
Samuels MH (2008) Cognitive function in untreated hypothyroidism and hyperthyroidism. Curr Opin Endocrinol Diabetes Obes 15:429–433. doi:10.1097/MED.0b013e32830eb84c
Zhu DF, Wang ZX, Zhang DR, Pan ZL, He S, Hu XP, Chen XC, Zhou JN (2006) fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain 129:2923–2930. doi:10.1093/brain/awl215
Mustian KM, Morrow GR, Carroll JK, Figueroa-Moseley CD, Jean-Pierre P, Williams GC (2007) Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist 12:52–67. doi:10.1634/theoncologist.12-S1-52
Chiu HY, Chiang PC, Miao NF, Lin EY, Tsai PS (2014) The effects of mind-body interventions on sleep in cancer patients: a meta-analysis of randomized controlled trials. J Clin Psychiatry 75:1215–1223. doi:10.4088/JCP.13r08918
Von Ah D, Storey S, Jansen CE, Allen DH (2013) Coping strategies and interventions for cognitive changes in patients with cancer. Semin Oncol Nurs 29:288–299. doi:10.1016/j.soncn.2013.08.009
Biegler KA, Chaoul MA, Cohen L (2009) Cancer, cognitive impairment, and meditation. Acta Oncol 48:18–26. doi:10.1080/02841860802415535
Cimprich B, Ronis DL (2003) An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nurs 26:284–292
Pharr JR, Dodge Francis C, Terry C, Clark MC (2014) Culture, caregiving, and health: exploring the influence of culture on family caregiver experiences. ISRN Public Health 2014:1–8. doi:10.1155/2014/689826
Lockwood S (2009) Contemporary issues in women’s cancers. Jones and Bartlett, Burlington
Acknowledgements
The research was funded by the 2014 Research Fund of the Chungnam National University (2014-0661-01). We are most appreciative of the study participants and research teams who made this research possible.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Research involving human participants and/or animals
1. Statement of human rights. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
2. Statement of welfare of animals. This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all participants included in the study.
Rights and permissions
About this article
Cite this article
Jung, M.S., Visovatti, M. Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma. Support Care Cancer 25, 915–923 (2017). https://doi.org/10.1007/s00520-016-3481-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3481-y